Notably, both of these studies relied on gene expression data only[20,21] and none could confirm the negative prognostic value of SATB1 expression in breast cancer demonstrated by Han et al.[3], who found immunohistochemical SATB1 expression to be an independent factor of poor prognosis[3]. Here, SATB1 is linked to breast carcinoma.